Wassana Jamnongkan

Khon Kaen, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Serum amino acid profiles in acute myocardial infarction: NMR metabolomics comparison of STEMI, NSTEMI, and controls.

Serum amino acid profiles in acute myocardial infarction: NMR metabolomics comparison of STEMI, NSTEMI, and controls.

Journal: Biomolecules & biomedicine

Published: May 31, 2026

Bile reinfusion is associated with shifts in host-microbiota metabolic profiles following cholangiocarcinoma-associated microbiota transplantation.

Bile reinfusion is associated with shifts in host-microbiota metabolic profiles following cholangiocarcinoma-associated microbiota transplantation.

Journal: Scientific reports

Published: April 18, 2025

Development of ready-to-use microtiter plates for enhanced ELISA detection of Opisthorchis viverrini antigens in urine samples.

Development of ready-to-use microtiter plates for enhanced ELISA detection of Opisthorchis viverrini antigens in urine samples.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Published: March 12, 2025

Transcriptomics analysis of in vivo Opisthorchis viverrini: Stage-specific gene expression and novel genes with stable expression in mammalian stages for opisthorchiasis intervention.

Transcriptomics analysis of in vivo Opisthorchis viverrini: Stage-specific gene expression and novel genes with stable expression in mammalian stages for opisthorchiasis intervention.

Journal: PLoS neglected tropical diseases

Published: December 31, 2024

Prognostic Values of Ferroptosis-Related Proteins ACSL4, SLC7A11, and CHAC1 in Cholangiocarcinoma.

Prognostic Values of Ferroptosis-Related Proteins ACSL4, SLC7A11, and CHAC1 in Cholangiocarcinoma.

Journal: Biomedicines

Published: August 08, 2024

Evaluation of HMGB1 Expression as a Clinical Biomarker for Cholangiocarcinoma.

Evaluation of HMGB1 Expression as a Clinical Biomarker for Cholangiocarcinoma.

Journal: Cancer genomics & proteomics

Published: July 25, 2024

Serum α2,6-sialylated glycoform of serotransferrin as a glycobiomarker for diagnosis and prediction of clinical severity in cholangiocarcinoma.

Serum α2,6-sialylated glycoform of serotransferrin as a glycobiomarker for diagnosis and prediction of clinical severity in cholangiocarcinoma.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: May 24, 2022

A fluorescence AuNPs-LISA: A new approach for Opisthorchis viverrini (Ov) antigen detection with a simple fluorescent enhancement strategy by surfactant micelle in urine samples.

A fluorescence AuNPs-LISA: A new approach for Opisthorchis viverrini (Ov) antigen detection with a simple fluorescent enhancement strategy by surfactant micelle in urine samples.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Published: August 22, 2020

AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine.

AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine.

Journal: Talanta

Published: September 13, 2019

Discovery of Serotransferrin Glycoforms: Novel Markers for Diagnosis of Liver Periductal Fibrosis and Prediction of Cholangiocarcinoma.

Discovery of Serotransferrin Glycoforms: Novel Markers for Diagnosis of Liver Periductal Fibrosis and Prediction of Cholangiocarcinoma.

Journal: Biomolecules

Published: August 29, 2019

Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis.

Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis.

Journal: PeerJ

Published: August 28, 2017

Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool.

Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: July 04, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026